Skip to content

Management of Dry eye syndrome

A Comparative study to evaluate the clinical efficacy of Yashtimadhu ghrita tarpana and Yashtimadhu ghrita Aschyothana in the management of Shushkakshipaka W.S.R to Dry eye syndrome - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/074620
Enrollment
100
Registered
2024-10-03
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H111- Conjunctival degenerations and deposits

Interventions

None listed

Sponsors

SVM AMC ILKAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having symptoms of Dry eye syndrome or Sushkakshipaka And minimum 1 year of exposure,

Exclusion criteria

Exclusion criteria: Who is unfit for Tarpana and Aschyothana therapy Congenital deformity of eyes Any inflammatory and infection conditions of eye

Design outcomes

Primary

MeasureTime frame
Signs and symptoms of Dry eye syndrome releaved.Timepoint: After 7th day of clinical trial

Secondary

MeasureTime frame
Increased tear secretion in eyesTimepoint: After 7th day of clinical trial

Countries

India

Contacts

Public ContactDr Vinod Jadhav

SVM AYURVEDIC MEDICAL COLLEGE ILKAL KARNATAKA BAGALKOT

vmjfiles82@gmail.com7204343105

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026